MedTrace Logo

Immunopathological Analysis in a French National Cohort of Membranous Nephropathy

NCT04326218 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2020-04-07

No results posted yet for this study

Summary

National cohort of all cases of membranous nephropathy (MN) during a 1 year period in France, based on a pathological and/or serological diagnostic, collecting the data on:

* incidence of MN
* prevalence of anti-PLA2R1 and anti-THSD7A
* clinical outcome one year after diagnosis or after relapse (complete remission, partial remission or persistent nephrotic syndrome)
* environmental risk factors for the onset of MN
* HLA markers
* patient care status in France

Conditions

Interventions

OTHER

Blood sample

Serum samples will be sent for centralised analyses in Nice. On these samples, different analysis will be performed : * anti-PLA2R1 and anti-THSD7A antibodies * anti-PLA2R1 and anti-THSD7A epitopes * HLA typing

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nice

    lead OTHER

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2024-07-01
Completion
2024-07-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04326218 on ClinicalTrials.gov